Pharvaris (PHVS) Institutional Ownership $20.50 -0.01 (-0.05%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Pharvaris (NASDAQ:PHVS)Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$77.81MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$55.93M Get PHVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pharvaris stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHVS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Pharvaris Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC5,700$106K0.0%N/A0.000% 11/16/2024 Geode Capital Management LLC36,977$685K0.0%+18.4%0.116% 11/15/2024 Barclays PLC5,700$106K0.0%N/A0.018% 11/15/2024 Public Employees Retirement System of Ohio3,100$57K0.0%N/A0.010% 11/15/2024 Jane Street Group LLC28,418$526K0.0%N/A0.089% 11/15/2024 Sphera Funds Management LTD.439,292$8.14M1.3%+8.9%1.380% Get the Latest News and Ratings for PHVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharvaris and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp53,980$1M0.0%N/A0.170% 11/15/2024 Patient Square Capital LP242,341$4.49M1.7%N/A0.761% 11/15/2024 HighVista Strategies LLC22,768$422K0.1%+35.9%0.000% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC48,896$906K0.0%N/A0.000% 11/13/2024 The Manufacturers Life Insurance Company 44,878$831K0.0%-18.5%0.000% 8/20/2024 Novo Holdings A S1,725,000$32.43M1.6%+47.7%0.000% 8/15/2024 Deerfield Management Company L.P. Series C1,397,279$26.27M0.4%+31.6%0.000% 8/14/2024 Marshall Wace LLP51,168$962K0.0%-12.0%0.161% 8/10/2024 Sofinnova Investments Inc.601,534$11.31M0.6%+2.9%1.889% 8/3/2024 TD Asset Management Inc85,816$1.61M0.0%-23.8%0.000% 5/16/2024 Bain Capital Life Sciences Investors LLC3,303,381$76.34M6.1%-15.4%0.000% 5/15/2024 venBio Partners LLC4,289,304$99.13M35.2%-12.8%0.000% 5/15/2024 Price T Rowe Associates Inc. MD757,915$17.52M0.0%-10.1%0.000% 2/15/2024 Blackstone Inc.100,000$2.81M0.0%N/A0.314% 2/14/2024 venBio Partners LLC4,919,504$137.99M20.7%+15.4%15.451% 2/14/2024 Commodore Capital LP800,000$22.44M2.0%N/A2.513% 2/13/2024 Bain Capital Life Sciences Investors LLC3,904,319$109.52M10.5%-18.4%0.000% 2/7/2024 Vivo Capital LLC285,000$7.99M0.7%N/A0.000% 12/7/2023 Hudson Bay Capital Management LP38,893$812K0.0%N/A0.122% 11/21/2023 Walleye Capital LLC81,017$1.69M0.0%+15.2%0.254% 11/13/2023 Foresite Capital Management V LLC33,142$692K1.1%-2.9%0.000% 11/13/2023 FMR LLC3,207,564$66.94M0.0%-5.3%0.000% 8/15/2023 Silverarc Capital Management LLC200,000$3.03M0.9%-64.2%0.000% 8/15/2023 Bain Capital Life Sciences Investors LLC4,868,784$73.71M7.6%+53.1%0.000% 8/14/2023 Cormorant Asset Management LP973,614$14.74M0.8%+19.2%0.000% 8/11/2023 VR Adviser LLC1,326,200$20.08M3.2%N/A0.000% 8/11/2023 General Atlantic L.P.4,406,252$66.71M1.1%+82.1%0.000% 8/11/2023 Foresite Capital Management IV LLC3,743,450$56.68M27.9%+15.3%0.000% 5/15/2023 Sio Capital Management LLC228,385$1.84M0.9%-19.9%0.717% 11/14/2022 Cormorant Asset Management LP1,207,500$9.26M0.6%+5.4%3.792% 11/14/2022Pictet Asset Management SA399,875$3.21M0.0%-13.6%1.256% 8/16/2022 venBio Partners LLC2,301,451$50.86M14.5%-0.1%7.228% 8/16/2022 Deerfield Management Company L.P. Series C1,190,343$26.31M0.5%-24.5%3.739% 8/9/2022Pictet Asset Management SA462,630$10.22M0.0%-14.0%1.453% New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now!5/17/2022 Eventide Asset Management LLC302,619$5.66M0.1%+23.6%0.950% 5/16/2022 Deerfield Management Company L.P. Series C1,577,078$28.60M0.6%-0.3%4.953% 5/16/2022 Viking Global Investors LP2,480,319$46.38M0.2%+1.0%7.790% 2/14/2022 Deerfield Management Company L.P. Series C1,581,331$22.76M0.5%-1.7%4.966% 2/14/2022 Suvretta Capital Management LLC827,540$11.91M0.2%N/A2.599% 2/14/2022 DAFNA Capital Management LLC36,720$528K0.1%+4.7%0.115% 2/14/2022 Novo Holdings A S516,321$7.43M0.4%+23.2%1.622% 2/10/2022Pictet Asset Management SA540,811$8.56M0.0%-2.9%1.699% 11/16/2021 VR Adviser LLC552,882$9.80M1.3%-38.8%1.736% 11/16/2021 Millennium Management LLC157,753$2.72M0.0%-19.9%0.495% 11/15/2021 Deerfield Management Company L.P. Series C1,608,471$28.52M0.6%+55.7%5.052% 11/10/2021 Goldman Sachs Group Inc.30,174$535K0.0%+8.6%0.095% 10/28/2021 Compagnie Lombard Odier SCmA16,670$287K0.0%+10.9%0.052% 8/17/2021 Millennium Management LLC196,967$3.58M0.0%-14.7%0.619% 8/17/2021 Caas Capital Management LP13,479$251K0.0%-73.0%0.042% 8/16/2021 Opaleye Management Inc.79,837$1.49M0.2%N/A0.251% 8/16/2021 Goldman Sachs Group Inc.27,792$518K0.0%+13.8%0.087% 8/13/2021 Geode Capital Management LLC18,643$338K0.0%+13.8%0.059% 8/13/2021 FMR LLC3,258,217$59.20M0.0%+17.7%10.233% 8/12/2021 JPMorgan Chase & Co.16,434$299K0.0%+18.5%0.052% 6/10/2021 Perceptive Advisors LLC27,000$755K0.0%N/A0.085% 5/27/2021 Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011% 5/19/2021 venBio Partners LLC2,303,310$64.45M6.1%N/A7.234% 5/18/2021 Millennium Management LLC230,900$6.48M0.0%N/A0.725% 5/18/2021 Zimmer Partners LP15,000$420K0.0%N/A0.047% 5/18/2021 Cormorant Asset Management LP864,143$23.81M0.5%N/A2.714% 5/18/2021 Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011% 5/17/2021 Viking Global Investors LP2,420,155$67.91M0.2%N/A7.601% 5/17/2021 Deerfield Management Company L.P. Series C1,032,757$28.90M0.6%N/A3.244% 5/17/2021 Perceptive Advisors LLC27,000$755K0.0%N/A0.085% 5/17/2021 General Atlantic LLC2,420,155$67.72M0.8%N/A7.601% 5/17/2021 Caas Capital Management LP50,000$1.40M0.0%N/A0.157% 5/17/2021Pinz Capital Management LP22,650$634K0.2%N/A0.071% 5/17/2021 Novo Holdings A S50,000$1.40M0.1%N/A0.157% 5/17/2021 Goldman Sachs Group Inc.24,428$683K0.0%N/A0.077% 5/13/2021 Rokos Capital Management LLP2,500$68K0.0%N/A0.008% 5/12/2021 Geode Capital Management LLC16,384$459K0.0%N/A0.051% 5/12/2021 Ensign Peak Advisors Inc5,000$140K0.0%N/A0.016% 5/12/2021 JPMorgan Chase & Co.13,874$389K0.0%N/A0.044% 5/7/2021BlackRock Inc.33,382$934K0.0%N/A0.105% (Data available from 1/1/2016 forward) PHVS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHVS shares? During the previous two years, 31 institutional investors and hedge funds held shares of Pharvaris. The most heavily invested institutionals were venBio Partners LLC ($99.13M), Bain Capital Life Sciences Investors LLC ($76.34M), FMR LLC ($66.94M), General Atlantic L.P. ($66.71M), Foresite Capital Management IV LLC ($56.68M), Novo Holdings A S ($32.43M), and Deerfield Management Company L.P. Series C ($26.27M).Learn more on PHVS's institutional investors. Which institutional investors have been buying Pharvaris stock? Of the 23 institutional investors that purchased Pharvaris stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: General Atlantic L.P. ($1.99M), Bain Capital Life Sciences Investors LLC ($1.69M), VR Adviser LLC ($1.33M), Commodore Capital LP ($800K), venBio Partners LLC ($654.83K), Novo Holdings A S ($556.97K), and Foresite Capital Management IV LLC ($496.52K). How much institutional buying is happening at Pharvaris? Institutional investors have bought a total of 8,889,026 shares in the last 24 months. This purchase volume represents approximately $166.64M in transactions. Which Pharvaris major shareholders have been selling company stock? Of the 10 institutional investors that sold Pharvaris stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($1.48M), venBio Partners LLC ($630.20K), Silverarc Capital Management LLC ($359.39K), FMR LLC ($179.59K), Price T Rowe Associates Inc. MD ($84.78K), Sio Capital Management LLC ($56.62K), and TD Asset Management Inc ($26.80K). How much institutional selling is happening at Pharvaris? Institutional investors have sold a total of 2,836,872 shares in the last 24 months. This volume of shares sold represents approximately $65.80M in transactions. Related Companies Alvotech Major Shareholders eFFECTOR Therapeutics Major Shareholders LAVA Therapeutics Major Shareholders PowerUp Acquisition Major Shareholders This page (NASDAQ:PHVS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
